Shilpa Medicare informs about disclosure

25 Jun 2024 Evaluate

Shilpa Medicare has informed that Bio Analytical Laboratory, Shilpa Medicare, Unit 7, Nacharam, Hyderabad, India was inspected by USFDA from 26th February to 1st March 2024. The inspection was concluded with zero 483 observations and no discussion items. The Agency has concluded that this inspection has now been closed with the issuance of the Establishment Inspection Report (EIR). The facility is classified as ‘No Action Indicated' (NAI). 

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

935.80 55.90 (6.35%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.